Pembrolizumab for the treatment of relapsed and refractory classical hodgkin lymphoma after autologous transplant and in transplant-naive patients

被引：0
|
作者：
Halahleh, K. [1 ]
Muradi, I. [2 ]
Al-Sawajneh, S. [1 ]
Saleh, Y. [1 ]
Barakat, F. [1 ]
Sultan, I. [1 ]
机构：
[1] King Hussein Canc Ctr & Fdn, Amman, Jordan
[2] Al Ahliyya Amman Univ, Al Salt, Jordan
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P430
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [41] Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma
    Moskowitz, Craig
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 331 - 338
  • [42] Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis
    Bair, Steven M.
    Strelec, Lauren
    Nagle, Sarah J.
    Nasta, Sunita D.
    Landsburg, Daniel J.
    Mato, Anthony R.
    Loren, Alison W.
    Schuster, Stephen J.
    Stadtmauer, Edward A.
    Svoboda, Jakub
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (09) : 879 - 884
  • [43] Impact of Novel Agents on the Outcomes of Patients with Classic Hodgkin Lymphoma That Relapsed after Autologous Stem Cell Transplant
    Tun, Aung M.
    Wang, Yucai
    Matin, Aasiya
    Inwards, David J.
    Johnston, Patrick B.
    Micallef, Ivana N.
    Porrata, Luis F.
    Villasboas, Jose C.
    Paludo, Jonas
    Tun, Han W.
    Rosenthal, Allison C.
    Cerhan, James R.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Ansell, Stephen M.
    BLOOD, 2021, 138
  • [44] Haploidentical Stem Cell Transplant for Relapsed or Refractory Hodgkin Lymphoma in Brazil
    Lacerda, M. P.
    Arrais-Rodrigues, C.
    Pereira, A.
    Novis, Y.
    Fonseca, M.
    Silva, R.
    Macedo, M.
    Hamerschlak, N.
    Esteves, I.
    Schmidt Filho, J.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S502 - S502
  • [45] Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation
    Kaloyannidis, Panayotis
    Hertzberg, Mark
    Webb, Kate
    Zomas, Athanasios
    Schrover, Rudolf
    Hurst, Michael
    Jacob, Ian
    Nikoglou, Thalia
    Connors, Joseph M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 540 - 549
  • [46] Brentuximab vedotin administered to platinum-refractory, transplant-naive Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status
    Onishi, Maika
    Graf, Solomon A.
    Holmberg, Leona
    Behnia, Sanaz
    Shustov, Andrei R.
    Schiavo, Karen
    Philip, Mary
    Libby, Edward N.
    Cassaday, Ryan D.
    Pagel, John M.
    Roden, Jennifer R.
    Maloney, David G.
    Green, Damian J.
    Till, Brian G.
    Press, Oliver W.
    Smith, Stephen D.
    Gopal, Ajay K.
    HEMATOLOGICAL ONCOLOGY, 2015, 33 (04) : 187 - 191
  • [47] Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma
    Forlenza, Christopher J.
    Rosenzweig, Jaclyn
    Mauguen, Audrey
    Buhtoiarov, Ilia
    Cuglievan, Branko
    Dave, Hema
    Deyell, Rebecca J.
    Flerlage, Jamie E.
    Franklin, Anna K.
    Krajewski, Jennifer
    Leger, Kasey J.
    Marks, Lianna J.
    Norris, Robin E.
    Pacheco, Martha
    Willen, Faye
    Yan, Adam Paul
    Harker-Murray, Paul D.
    Giulino-Roth, Lisa
    BLOOD ADVANCES, 2023, 7 (13) : 3225 - 3231
  • [48] Survival after autologous versus allogeneic transplantation in patients with relapsed and refractory Hodgkin lymphoma
    Fakhri, Bita
    Yilmaz, Elif
    Gao, Feng
    Ambinder, Richard F.
    Jones, Richard
    Bartlett, Nancy L.
    Cashen, Amanda
    Wagner-Johnston, Nina
    LEUKEMIA & LYMPHOMA, 2021, 62 (10) : 2408 - 2415
  • [49] A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma
    Shea, Lauren
    Watkins, Marcus P.
    Wan, Fei
    Cashen, Amanda F.
    Wagner-Johnston, Nina D.
    Jacoby, Meagan A.
    Abboud, Camille N.
    Dipersio, John F.
    Hurd, David D.
    Jaglowski, Samantha M.
    Bartlett, Nancy L.
    Fehniger, Todd A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (12) : 2223 - 2228
  • [50] PHASE II STUDY OF ORAL PANOBINOSTAT IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANT
    Younes, A.
    Sureda, A.
    Ben-Yehuda, D.
    Ong, T. C.
    Tan, D.
    Engert, A.
    Le Corre, C.
    Gallagher, J.
    Hirawat, S.
    Prince, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 34 - 35
12345